top
Search terms
Results 1 - 10 of 24 - ordered by :
Pages: 1 2 3
Ehjournal

During the last decades, controversial discussions were held around optimal blood pressure (BP) values, providing the largest benefit of preventing cardiovascular events in patients with different ...

European Heart Journal, Böhm, Michael, Mahfoud, Felix

Date : 14/11/2018 Item size : 119667 bytes
Ehjournal

Achieved diastolic blood pressure and pulse pressure at target systolic blood pressure (120–140 mmHg) and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND ...

European Heart Journal, Böhm, Michael, Schumacher, Helmut, Teo, Koon K, Lonn, Eva, Mahfoud, Felix, Mann, Johannes F E, Mancia, Giuseppe, Redon, Josep, Schmieder, Roland, Weber, Michael, Sliwa, ...

Date : 01/09/2018 Item size : 342664 bytes
Ehjournal

The Supplemental Benefit of an Angiotensin Receptor Blocker in Hypertensive Patients with Stable Heart Failure Using Olmesartan (SUPPORT, NCT00417222) trial, a prospective, randomized, open-label ...

European Heart Journal, Ewen, Sebastian, Böhm, Michael

Date : 14/04/2015
Ehjournal

The Supplemental Benefit of an Angiotensin Receptor Blocker in Hypertensive Patients with Stable Heart Failure Using Olmesartan (SUPPORT, NCT00417222) trial, a prospective, randomized, open-label ...

European Heart Journal, Ewen, Sebastian, Böhm, Michael

Date : 14/04/2015 Item size : 200132 bytes
Ehjournal

Methods and results In this randomized, placebo-controlled, double-blind trial, we assigned 1012 patients with acute STEMI and without a history of heart failure to receive either eplerenone (2550 mg ...

European Heart Journal, Montalescot, Gilles, Pitt, Bertram, Lopez de Sa, Esteban, Hamm, Christian W., Flather, Marcus, Verheugt, Freek, Shi, Harry, Turgonyi, Eva, Orri, Miguel, Vincent, John, Zannad, ...

Date : 07/09/2014
Ehjournal

Methods and results In this randomized, placebo-controlled, double-blind trial, we assigned 1012 patients with acute STEMI and without a history of heart failure to receive either eplerenone (2550 mg ...

European Heart Journal, Montalescot, Gilles, Pitt, Bertram, Lopez de Sa, Esteban, Hamm, Christian W., Flather, Marcus, Verheugt, Freek, Shi, Harry, Turgonyi, Eva, Orri, Miguel, Vincent, John, Zannad, ...

Date : 07/09/2014 Item size : 377221 bytes
Ehjournal

Abstract Aims To test the effect of ivabradine on the outcomes in a broad population with left-ventricular (LV) systolic dysfunction with coronary artery disease (CAD) and/or heart failure ...

European Heart Journal, Fox, Kim, Komajda, Michel, Ford, Ian, Robertson, Michele, Böhm, Michael, Borer, Jeffrey S., Steg, Philippe Gabriel, Tavazzi, Luigi, Tendera, Michal, Ferrari, Roberto, ...

Date : 01/08/2013
Ehjournal

Abstract Aims To test the effect of ivabradine on the outcomes in a broad population with left-ventricular (LV) systolic dysfunction with coronary artery disease (CAD) and/or heart failure ...

European Heart Journal, Fox, Kim, Komajda, Michel, Ford, Ian, Robertson, Michele, Böhm, Michael, Borer, Jeffrey S., Steg, Philippe Gabriel, Tavazzi, Luigi, Tendera, Michal, Ferrari, Roberto, ...

Date : 01/08/2013 Item size : 255149 bytes
Ehjournal

Methods and results Plasma Ang-1 and Ang-2 were determined by the enzyme immunoassay in patients with CS (n = 96), uncomplicated acute myocardial infarction (AMI, n = 20) and age-matched healthy ...

European Heart Journal, Link, Andreas, Pöss, Janine, Rbah, Ranja, Barth, Christine, Feth, Luisa, Selejan, Simina, Böhm, Michael

Date : 07/06/2013 Item size : 323190 bytes
Ehjournal

Methods and results Plasma Ang-1 and Ang-2 were determined by the enzyme immunoassay in patients with CS (n = 96), uncomplicated acute myocardial infarction (AMI, n = 20) and age-matched healthy ...

European Heart Journal, Link, Andreas, Pöss, Janine, Rbah, Ranja, Barth, Christine, Feth, Luisa, Selejan, Simina, Böhm, Michael

Date : 07/06/2013